Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Molecular Partners Ag (MOLN) Net Margin: 2020-2025

Historic Net Margin for Molecular Partners Ag (MOLN) over the last 5 years, with Sep 2025 value amounting to -7,538.85%.

  • Molecular Partners Ag's Net Margin fell 513004.00% to -7,538.85% in Q3 2025 from the same period last year, while for Sep 2025 it was -872.02%, marking a year-over-year increase of 2509.00%. This contributed to the annual value of -1,087.38% for FY2024, which is 20668.00% down from last year.
  • As of Q3 2025, Molecular Partners Ag's Net Margin stood at -7,538.85%, which was down 1,193.93% from -582.63% recorded in Q2 2025.
  • In the past 5 years, Molecular Partners Ag's Net Margin registered a high of 88.62% during Q1 2022, and its lowest value of -7,538.85% during Q3 2025.
  • Moreover, its 3-year median value for Net Margin was -972.40% (2024), whereas its average is -1,832.12%.
  • In the last 5 years, Molecular Partners Ag's Net Margin plummeted by 616,925bps in 2021 and then surged by 287,988bps in 2024.
  • Molecular Partners Ag's Net Margin (Quarterly) stood at -348.40% in 2021, then plummeted by 21,514bps to 62.15% in 2022, then tumbled by 94,301bps to -880.86% in 2023, then slumped by 20,671bps to -1,087.57% in 2024, then slumped by 513,004bps to -7,538.85% in 2025.
  • Its last three reported values are -7,538.85% in Q3 2025, -582.63% for Q2 2025, and -1,481.63% during Q1 2025.